Growth Metrics

Palisade Bio (PALI) Cash from Operations Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 37.40%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 20.11%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 16.64%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -7.60%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 34.32%
10 Palisade Bio 439.25 Mn 309.68 Mn - -3.33%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -3.33%
Dec 31, 2025 1.66%
Sep 30, 2025 -5.34%
Jun 30, 2025 17.62%
Mar 31, 2025 14.74%
Dec 31, 2024 7.97%
Sep 30, 2024 -4.49%
Jun 30, 2024 23.19%
Mar 31, 2024 -36.51%
Dec 31, 2023 -21.05%
Sep 30, 2023 -45.23%
Jun 30, 2023 -48.36%
Mar 31, 2023 -28.09%
Dec 31, 2022 -17.29%
Sep 30, 2022 -17.02%
Jun 30, 2022 -25.51%
Mar 31, 2022 -31.22%
Dec 31, 2021 -22.60%
Sep 30, 2021 -18.17%
Jun 30, 2021 -45.18%
Mar 31, 2021 12.20%
Dec 31, 2020 12.19%
Sep 30, 2020 36.05%
Jun 30, 2020 41.55%
Mar 31, 2020 27.68%
Dec 31, 2019 20.52%
Sep 30, 2019 24.88%
Jun 30, 2019 22.80%
Mar 31, 2019 21.83%
Dec 31, 2018 24.80%
Sep 30, 2018 32.90%
Jun 30, 2018 19.32%
Mar 31, 2018 26.86%
Dec 31, 2017 13.07%
Sep 30, 2017 -2.32%
Jun 30, 2017 -11.81%
Mar 31, 2017 -17.81%
Dec 31, 2016 -18.12%
Sep 30, 2016 -25.89%
Jun 30, 2016 -2.06%
Mar 31, 2016 -11.55%
Dec 31, 2015 -15.69%
Sep 30, 2015 -57.12%
Jun 30, 2015 -25.36%
Mar 31, 2015 -30.98%
Dec 31, 2014 -24.98%
Sep 30, 2014 -19.58%
Jun 30, 2014 -2.93%
Mar 31, 2014 -5.83%
Dec 31, 2013 3.43%
Sep 30, 2013 1.58%